As exemplified by the occurrence of diabetes in carriers of mutations affecting insulin production, any deficit along this supply chain can deplete beta cells of new insulin granule stores, thereby hampering their competence for glucose-stimulated secretion. Here, INS is linked to diabetes mellitus.